Title:
安定トリエンチン製剤
Document Type and Number:
Japanese Patent JP6889116
Kind Code:
B2
Abstract:
Provided are pharmaceutical dosage forms comprising (i) trientine or a pharmaceutically acceptable salt of trientine, in a (ii) sealed packaging. The sealed packaging provides a high barrier protection against air, moisture and light and prevents exposure of the drug to conditions that facilitate its decomposition. The pharmaceutical dosage forms are useful for treating diseases or conditions where excess copper is not removed from the body, e.g., Wilson's disease.
Inventors:
Samuel Dee. Waxal
Application Number:
JP2017559292A
Publication Date:
June 18, 2021
Filing Date:
February 03, 2016
Export Citation:
Assignee:
Cadmon Pharmaceuticals, Limited Liability Company
International Classes:
A61K31/132; A61J1/03; A61K9/20; A61K9/48; A61P1/16; A61P39/04
Domestic Patent References:
| JP2008525527A | ||||
| JP2007246092A | ||||
| JP6135825A |
Foreign References:
| US20060100278 | ||||
| US20090030079 | ||||
| US20140262883 |
Other References:
CAPSULES SYPRINE(登録商標),1999年 5月,p.1-4
Attorney, Agent or Firm:
Atsushi Aoki
Shinji Mitsuhashi
Yoichi Watanabe
Masaru Nakajima
Ryotaro Takei
Hiroaki Oshima
Shinji Mitsuhashi
Yoichi Watanabe
Masaru Nakajima
Ryotaro Takei
Hiroaki Oshima